Valuation: Boryung Corporation

Market Cap 673B 463M 406M 378M 348M 652M 44.21B 663M 4.49B 1.76B 21.93B 1.74B 1.7B 75.75B P/E 2026 *
10.3x
P/E 2027 * 10x
Enterprise Value 673B 463M 406M 378M 348M 652M 44.21B 663M 4.49B 1.76B 21.93B 1.74B 1.7B 75.75B EV / Sales 2026 *
0.64x
EV / Sales 2027 * 0.62x
Free-Float
32.71%
Yield 2026 *
2.01%
Yield 2027 * 2.01%
1 day-2.80%
1 week-1.97%
Current month-5.23%
1 month-1.85%
3 months-20.70%
6 months-12.99%
Current year-11.54%
1 week 7,870
Extreme 7870
8,400
1 month 7,870
Extreme 7870
8,680
Current year 7,870
Extreme 7870
10,800
1 year 7,870
Extreme 7870
10,800
3 years 7,680
Extreme 7680
13,750
5 years 7,440
Extreme 7440
19,500
10 years 5,743.71
Extreme 5743.7069
25,083.33
Manager TitleAgeSince
Chief Executive Officer 41 2022-03-24
Director of Finance/CFO 51 -
Chief Tech/Sci/R&D Officer 55 -
Director TitleAgeSince
Director/Board Member 39 2022-03-24
Director/Board Member 94 -
Chairman 68 2014-05-18
Date Insider Type Main position Quantity % Market Cap.
6/12/25 Buy 117,572 0.1355%
6/12/25 Buy

Director

400,000 0.4609%
5/22/25 Buy

Responsable ventes & marketing

235 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-2.80%-1.97%-6.78%-2.69% 472M
+0.09%+1.91%+15.77%+73.19% 49.38B
+1.14%+4.83%+59.21%+120.10% 36.35B
+0.31%+2.11%-8.20%+22.98% 11.87B
+0.27%-2.46%+10.43%+73.76% 11.53B
+0.38%+1.16%+31.33%+131.86% 8.99B
+2.61%+2.97%+49.14%-4.80% 7B
-0.51%-0.85%+11.77%+33.26% 6.76B
+0.54%-0.16%+1.77%+178.77% 6.46B
-1.32%-6.80%-33.10%-2.26% 5.49B
Average -0.01%-0.86%+13.13%+62.42% 14.43B
Weighted average by Cap. +0.40%+0.32%+24.16%+80.53%

Financials

2026 *2027 *
Net sales 1,058B 727M 638M 594M 546M 1.02B 69.45B 1.04B 7.05B 2.76B 34.44B 2.73B 2.67B 119B 1,084B 745M 654M 609M 560M 1.05B 71.19B 1.07B 7.22B 2.83B 35.31B 2.8B 2.74B 122B
Net income 66.2B 45.5M 39.93M 37.18M 34.2M 64.11M 4.35B 65.21M 441M 173M 2.16B 171M 167M 7.45B 68.2B 46.87M 41.14M 38.31M 35.23M 66.05M 4.48B 67.18M 454M 178M 2.22B 176M 172M 7.67B
Net Debt - -
Logo Boryung Corporation
Boryung Corp, formerly Boryung Pharm Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of pharmaceutical products. The Company mainly manufactures and distributes pharmaceutical products including antihypertensive drugs, gastrointestinal disorder drugs, antibiotics, gastric ulcer drugs, oral antibiotics, anticancer drugs and antihyperlipidemic drugs, among others. The Company distributes its products in domestic and overseas markets.
Employees
1,533
Date Price Change Volume
26-07-28 ₩7,970.00 -2.80% 103,698
26-07-27 ₩8,200.00 -0.61% 65,379
26-07-24 ₩8,250.00 +0.24% 86,200
26-07-23 ₩8,230.00 +3.26% 70,728
26-07-22 ₩7,970.00 -1.97% 87,425
Trader
-
Investor
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
7,970.00KRW
Average target price
14,000.00KRW
Spread / Average Target
+75.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A003850 Stock